Morgan, Ann W., Barrett , Jennifer H., Griffiths, Bridget, Subramanian, Deepak , Robinson, Jim I. , Keyte, Viki H., Ali, Manir, Jones, E. A. (Elizabeth A.), Old, Robert W. , Ponchel, Frederique , Boylston, Arthur W., Deva Situnayake, R, Markham, Alexander F, Emery, Paul and Isaacs, John D.. (2005) Analysis of Fcγ receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3B. Arthritis Research & Therapy, Vol.8 (No.R5). ISSN 1478-6354

Preview

PDF WRAP_Old_Analysis_receptor.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Download (249Kb)

Abstract

The Fcγ receptors play important roles in the initiation and regulation of many immunological and inflammatory processes, and genetic variants (FCGR) have been associated with numerous autoimmune and infectious diseases. The data in rheumatoid arthritis (RA) are conflicting and we previously demonstrated an association between FCGR3A and RA. In view of the close molecular proximity with FCGR2A, FCGR2B and FCGR3B, additional polymorphisms within these genes and FCGR haplotypes were examined to refine the extent of association with RA. Biallelic polymorphisms in FCGR2A, FCGR2B and FCGR3B were examined for association with RA in two well characterized UK Caucasian and North Indian/Pakistani cohorts, in which FCGR3A genotyping had previously been undertaken. Haplotype frequencies and linkage disequilibrium were estimated across the FCGR locus and a model-free analysis was performed to determine association with RA. This was followed by regression analysis, allowing for phase uncertainty, to identify the particular haplotype(s) that influences disease risk. Our results reveal that FCGR2A, FCGR2B and FCGR3B were not associated with RA. The haplotype with the strongest association with RA susceptibility was the FCGR3A–FCGR3B 158V-NA2 haplotype (odds ratio 3.18, 95% confidence interval 1.13–8.92 [P = 0.03] for homozygotes compared with all genotypes). The association was stronger in the presence of nodules (odds ratio 5.03, 95% confidence interval 1.44–17.56; P = 0.01). This haplotype was also more common in North Indian/Pakistani RA patients than in control individuals, but not significantly so. Logistic regression analyses suggested that FCGR3A remained the most significant gene at this locus. The increased association with an FCGR3A–FCGR3B haplotype suggests that other polymorphic variants within FCGR3A or FCGR3B, or in linkage disequilibrium with this haplotype, may additionally contribute to disease pathogenesis.

Item Type:	Journal Article
Subjects:	R Medicine > R Medicine (General) Q Science > QR Microbiology
Divisions:	Faculty of Science > Life Sciences (2010- ) > Biological Sciences ( -2010)
Library of Congress Subject Headings (LCSH):	Rheumatoid arthritis, Gene mapping
Journal or Publication Title:	Arthritis Research & Therapy
Publisher:	BioMed Central Ltd.
ISSN:	1478-6354
Date:	10 November 2005
Volume:	Vol.8
Number:	No.R5
Identification Number:	10.1186/ar1847
Status:	Peer Reviewed
Access rights to Published version:	Open Access
Funder:	Arthritis Research Campaign (Organization), Medical Research Council (Great Britain) (MRC)
References:	1. Lin JP, Cash JM, Doyle SZ, Peden S, Kanik K, Amos CI, Bale SJ, Wilder RL: Familial clustering of rheumatoid arthritis with other autoimmune diseases. Hum Genet 1998, 103:475-482. 2. Williams DG: Autoimmunity in rheumatoid arthritis. In Rheumatology Edited by: Klippel JH, Dieppe PA. London: Mosby-Year Book Europe; 1998:3.9.1-3.9.14. 3. Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T: Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005, 64:196-201. 4. Smolen JS, Steiner G: Are autoantibodies active players or epiphenomena? Curr Opin Rheumatol 1998, 10:201-206. 5. Salmon JE, Pricop L: Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001, 44:739-750. 6. Dijstelbloem HM, van de Winkel JG, Kallenberg CG: Inflammation in autoimmunity: receptors for IgG revisited. Trends Immunol 2001, 22:510-516. 7. Pricop L, Redecha P, Teillaud JL, Frey J, Fridman WH, Sautès-Fridman C, Salmon JE: Differential modulation of stimulatory and inhibitory Fcγ receptors on human monocytes by Th1 and Th2 cytokines. J Immunol 2001, 166:531-537. 8. Ravetch JV, Lanier LL: Immune inhibitory receptors. Science 2000, 290:84-89. 9. Nabbe KC, Blom AB, Holthuysen AE, Boross P, Roth J, Verbeek S, Van Lent PL, van den Berg WB: Coordinate expression of activating Fcγ receptors I and III and inhibiting Fcγ receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis. Arthritis Rheum 2003, 48:255-265. 10. Kleinau S, Martinsson P, Heyman B: Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors. J Exp Med 2000, 191:1611-1616. 11. Morgan AW, Griffiths B, Ponchel F, Montague BM, Ali M, Gardner PP, Gooi HC, Situnayake RD, Markham AF, Emery P, Isaacs JD: Fcγ receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum 2000, 43:2328-2334. 12. Morgan AW, Keyte VH, Babbage SJ, Robinson JI, Ponchel F, Barrett JH, Bhakta BB, Bingham SJ, Buch MH, Conaghan PG, et al.: FcγRIIIA-158V and rheumatoid arthritis: a confirmation study. Rheumatology (Oxford) 2003, 42:528-533. 13. Nieto A, Cáliz R, Pascual M, Matarán L, García S, Martin J: Involvement of Fcγ receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum 2000, 43:735-739. 14. Milicic A, Misra R, Agarwal S, Aggarwal A, Brown MA, Wordsworth BP: The F158V polymorphism in FcγRIIIA shows disparate associations with rheumatoid arthritis in two genetically distinct populations. Ann Rheum Dis 2002, 61:1021-1023. 15. Kyogoku C, Tsuchiya N, Matsuta K, Tokunaga K: Studies on the association of Fcγ receptor IIA, IIB, IIIA and IIIB polymorphisms with rheumatoid arthritis in the Japanese: evidence for a genetic interaction between HLA-DRB1 and FCGR3A. Genes Immun 2002, 3:488-493. 16. Brun JG, Madland TM, Vedeler CA: Immunoglobulin G Fc-receptor (FcγR) IIA, IIIA, and IIIB polymorphisms related to disease severity in rheumatoid arthritis. J Rheumatol 2002, 29:1135-1140. 17. Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martin J, de la Concha EG: Genetic polymorphisms in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun 2003, 4:117-121. 18. Radstake TR, Petit E, Pierlot C, van de Putte LB, Cornelis F, Barrera P: Role of Fcγ receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritis. J Rheumatol 2003, 30:926-933. 19. Cardon LR, Bell JI: Association study designs for complex diseases. Nat Rev Genet 2001, 2:91-99. 20. Su Y, Brooks DG, Li L, Lepercq J, Trofatter JA, Ravetch JV, Lebo RV: Myelin protein zero gene mutated in Charcot-Marie-tooth type 1B patients. Proc Natl Acad Sci USA 1993, 90:10856-10860. 21. Griffiths B, Situnayake RD, Clark B, Tennant A, Salmon M, Emery P: Racial origin and its effect on disease expression and HLADRB1 types in patients with rheumatoid arthritis: a matched cross-sectional study. Rheumatology (Oxford) 2000, 39:857-864. 22. National Center for Biotechnology Information (NCBI) [http:// www.ncbi.nlm.nih.gov] 23. Ensembl [http://www.ensembl.org/index.html] 24. Computational Biology at Oak Ridge National Laboratory (ORNL) [http://genome.ornl.gov] 25. Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV: Organisation of the human and mouse low-affinity FcγR genes: duplication and recombination. Science 1990, 248:732-735. 26. Warmerdam PAM, van den Herik-Oudijk IE, Parren PW, Westerdaal NA, van de Winkel JG, Capel PJ: Interaction of a human FcγRIIb1 (CD32) isoform with murine and human IgG subclasses. Int Immunol 1993, 5:239-247. 27. van den Herik-Oudijk IE, Westerdaal NA, Henriquez NV, Capel PJ, van de Winkel JG: Functional analysis of human FcγRII (CD32) isoforms expressed in B lymphocytes. J Immunol 1994, 152:574-585. 28. Norris CF, Pricop L, Millard SS, Taylor SM, Surrey S, Schwartz E, Salmon JE, McKenzie SE: A naturally occurring mutation in FcγRIIA: a Q to K127 change confers unique IgG binding properties to the R131 allelic form of the receptor. Blood 1998, 91:656-662. 29. Smyth LJ, Snowden N, Carthy D, Papasteriades C, Hajeer A, Ollier WE: FcγRIIa polymorphism in systemic lupus erythematosus. Ann Rheum Dis 1997, 56:744-746. 30. de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AE: Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 1995, 86:2403-2413. 31. Morgan AW, Griffiths B, Barrett JH, Markham AF, Emery P, Isaacs JD: Fcγ receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Reply. Arthritis Rheum 2002, 46:557-559. 32. Zhao JH, Curtis D, Sham PC: Model-free analysis and permutation tests for allelic associations. Hum Hered 2000, 50:133-139. 33. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG: Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002, 53:79-91. 34. Cordell HJ, Clayton DG: A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in Type 1 diabetes. Am J Hum Genet 2002, 70:124-141. 35. Su K, Wu J, Edberg JC, McKenzie SE, Kimberly RP: Genomic organization of classical human low-affinity Fcgamma receptor genes. Genes Immun 2002, 3 Suppl 1:S51-S56. 36. Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, Schork NJ: Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 2001, 11:143-151. 37. Stram DO, Leigh Pearce C, Bretsky P, Freedman M, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE, Thomas DC: Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 2003, 55:179-190. 38. Fallin D, Schork NJ: Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximisation algorithm for unphased diploid genotype data. Am J Hum Genet 2000, 67:947-959. 39. Blom AB, Radstake TR, Holthuysen AE, Slöetjes AW, Pesman GJ, Sweep FG, van de Loo FA, Joosten LA, Barrera P, Van Lent PL, van den Berg WB: Increased expression of Fcγ receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor α and matrix metalloproteinase. Arthritis Rheum 2003, 48:1002-1014. 40. Hepburn AL, Mason JC, Davies KA: Expression of Fcγ and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford) 2004, 43:547-554. 41. Wijngaarden S, van Roon JA, Bijlsma JW, van de Winkel JG, Lafeber FP: Fcγ receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rates who do not use anti-rheumatic drugs. Rheumatology (Oxford) 2003, 42:681-688. 42. Regnault A, Lankar D, Lacabanne V, Rodriguez A, Théry C, Rescigno M, Saito T, Verbeek S, Bonnerot C, Ricciardi-Castagnoli P, Amigorena S: Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class Irestricted antigen presentation after immune complex internalisation. J Exp Med 1999, 189:371-380. 43. Chuang FY, Sassaroli M, Unkeless JC: Convergence of Fcγ receptor IIA and Fcγ receptor IIIB signaling pathways in human neutrophils. J Immunol 2000, 164:350-360. 44. Salmon JE, Millard SS, Brogle NL, Kimberly RP: Fcγ receptor IIIb enhances Fcγ receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest 1995, 95:2877-2885. 45. Salmon JE, Edberg JC, Kimberly RP: Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J Clin Invest 1990, 85:1287-1295. 46. Kimberly RP, Salmon JE, Edberg JC: Receptors for immunoglobulin G. Molecular diversity and implications for disease. Arthritis Rheum 1995, 38:306-314. 47. Koene HR, Kleijer M, Roos D, de Haas M, Von dem Borne AE: Fc gamma RIIIB gene duplication: evidence for presence and expression of three distinct Fc gamma RIIIB genes in NA(1+,2+)SH(+) individuals. Blood 1998, 91:673-679. 48. Muniz-Diaz E, Madoz P, de la Calle Martin O, Puig L: The polymorphonuclear neutrophil Fc gamma RIIIb deficiency is more frequent than hitherto assumed. Blood 1995, 86:3999. 49. Kyogoku C, Tsuchiya N, Wu H, Tsao BP, Tokunaga K: Association of Fcgamma receptor IIA, but not IIB and IIIA, polymorphisms with systemic lupus erythematosus: A family-based association study in Caucasians. Arthritis Rheum 2004, 50:671-673. 50. Jiang Y, Hirose S, Abe M, Sanokawa-Akakura R, Ohtsuji M, Mi X, Li N, Xiu Y, Zhang D, Shirai J, et al.: Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 2000, 51:429-435. 51. Pritchard NR, Cutler AJ, Uribe S, Chadban SJ, Morley BJ, Smith KG: Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII. Curr Biol 2000, 10:227-230. 52. Johansson AC, Sundler M, Kjellén P, Johannesson M, Cook A, Lindqvist AK, Nakken B, Bolstad AI, Jonsson R, Alarcón-Riquelme M, Holmdahl R: Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcγRIIb and is not associated with loci controlling diabetes. Eur J Immunol 2001, 31:1847-1856.
URI:	http://wrap.warwick.ac.uk/id/eprint/583

Request changes to a record

Actions (login required)

View Item